151 related articles for article (PubMed ID: 24989923)
21. Use of high-risk human papillomavirus testing in patients with low-grade squamous intraepithelial lesions.
Levi AW; Harigopal M; Hui P; Schofield K; Chhieng DC
Cancer Cytopathol; 2011 Aug; 119(4):228-34. PubMed ID: 21732551
[TBL] [Abstract][Full Text] [Related]
22. Human papillomavirus test with cytology triage in organized screening for cervical cancer.
Veijalainen O; Kares S; Kujala P; Tirkkonen M; Vuento R; Kholová I; Luukkaala T; Osuala V; Mäenpää J
Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1220-1227. PubMed ID: 27591407
[TBL] [Abstract][Full Text] [Related]
23. "Low-grade positivity" of HPV viral load after atypical squamous cells of undetermined significance (ASC-US) cytology identifies women at low-risk for cervical intraepithelial neoplasia grade 2 and 3.
Origoni M; Carminati G; Sideri M; Clementi M; Rolla S; Candiani M
Eur J Gynaecol Oncol; 2012; 33(3):261-4. PubMed ID: 22873095
[TBL] [Abstract][Full Text] [Related]
24. Human Papillomavirus Test for Triage of Japanese Women With Low-Grade Squamous Intraepithelial Lesions.
Iwata T; Hasegawa T; Ochiai K; Takizawa K; Umezawa S; Kuramoto H; Ohmura M; Kubushiro K; Arai H; Sakamoto M; Motoyama T; Watanabe K; Aoki D
Reprod Sci; 2015 Dec; 22(12):1509-15. PubMed ID: 26092278
[TBL] [Abstract][Full Text] [Related]
25. Value of endocervical margin and high-risk human papillomavirus status after conization for high-grade cervical intraepithelial neoplasia, adenocarcinoma in situ, and microinvasive carcinoma of the uterine cervix.
Kong TW; Son JH; Chang SJ; Paek J; Lee Y; Ryu HS
Gynecol Oncol; 2014 Dec; 135(3):468-73. PubMed ID: 25284039
[TBL] [Abstract][Full Text] [Related]
26. Comparison of HPV genotypes and viral load between different sites of genital tract: the significance for cervical cancer screening.
Zhang SK; Ci PW; Velicer C; Kang LN; Liu B; Cui JF; Chen F; Zhang X; Chang IJ; Roberts CC; Smith JS; Chen W; Qiao YL
Cancer Epidemiol; 2014 Apr; 38(2):168-73. PubMed ID: 24522235
[TBL] [Abstract][Full Text] [Related]
27. Human papillomavirus genotyping as a reliable prognostic marker of recurrence after loop electrosurgical excision procedure for high-grade cervical intraepithelial neoplasia (CIN2-3) especially in postmenopausal women.
Kang WD; Kim SM
Menopause; 2016 Jan; 23(1):81-6. PubMed ID: 26057824
[TBL] [Abstract][Full Text] [Related]
28. Semi-quantitative HPV viral load in patients with ASC-US cytology: viral load correlates strongly with the presence of CIN but only weakly with its severity.
Lee SJ; Kim WY; Shim SH; Cho SH; Oh IK; Hwang TS; Kim SN; Kang SB
Cytopathology; 2015 Feb; 26(1):19-25. PubMed ID: 24766438
[TBL] [Abstract][Full Text] [Related]
29. Follow-up by combined cytology and human papillomavirus testing for patients post-cone biopsy: results of a long-term follow-up.
Bar-Am A; Gamzu R; Levin I; Fainaru O; Niv J; Almog B
Gynecol Oncol; 2003 Oct; 91(1):149-53. PubMed ID: 14529675
[TBL] [Abstract][Full Text] [Related]
30. [Risk factors in invasive cervical cancer among Mexican women].
Tirado-Gómez LL; Mohar-Betancourt A; López-Cervantes M; García-Carrancá A; Franco-Marina F; Borges G
Salud Publica Mex; 2005; 47(5):342-50. PubMed ID: 16323527
[TBL] [Abstract][Full Text] [Related]
31. Viral load of high-risk human papillomaviruses as reliable clinical predictor for the presence of cervical lesions.
Schmitt M; Depuydt C; Benoy I; Bogers J; Antoine J; Pawlita M; Arbyn M;
Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):406-14. PubMed ID: 23334590
[TBL] [Abstract][Full Text] [Related]
32. Factors predicting persistence of high-risk human papillomavirus (HPV) infections in women prospectively followed-up in three New Independent States (NIS) of the former Soviet Union.
Syrjänen S; Shabalova I; Petrovichev N; Kozachenko V; Zakharova T; Pajanidi J; Podistov J; Chemeris G; Sozaeva L; Lipova E; Tsidaeva I; Ivanchenko O; Pshepurko A; Zakharenko S; Nerovjna R; Kljukina L; Erokhina O; Branovskaja M; Nikitina M; Grunberga V; Grunberg A; Juschenko A; Cintorino M; Santopietro R; Tosi P; Syrjänen K
Eur J Gynaecol Oncol; 2005; 26(5):491-8. PubMed ID: 16285563
[TBL] [Abstract][Full Text] [Related]
33. [Correlations of high-risk human papillomaviral load to cervical intraepithelial neoplasia grades, expression of Ki-67 and P6ink4a and follow-up].
Yi W; Wang JL; Li XH; Wei LH
Ai Zheng; 2008 May; 27(5):520-4. PubMed ID: 18479603
[TBL] [Abstract][Full Text] [Related]
34. [Performance of vaginal self-sampling high-risk HPV genotyping as primary and combining cytology or viral load as secondary in cervical cancer screening].
Guo CL; Luo HX; Wang C; Qu XF; Yang B; Belinson JL; Du H; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2021 Apr; 56(4):271-279. PubMed ID: 33902239
[No Abstract] [Full Text] [Related]
35. [Relationship between cervical lesions and the type-specific viral load of high risk HPV reflected by the Ct value of Cobas 4800 HPV system].
Duan LF; Du H; Xiao AM; Wang C; Huang X; Zhao MF; Men HJ; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2019 Jul; 54(7):458-463. PubMed ID: 31365958
[No Abstract] [Full Text] [Related]
36. Human papilloma virus correlates of high grade cervical dysplasia in HIV-infected women in Mombasa, Kenya: a cross-sectional analysis.
Menon S; Luchters S; Rossi R; Callens S; Kishor M; Bogers J; Vanden Broeck D
Virol J; 2018 Mar; 15(1):54. PubMed ID: 29587796
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of Viral Load as a Triage Strategy With Primary High-Risk Human Papillomavirus Cervical Cancer Screening.
Luo H; Belinson JL; Du H; Liu Z; Zhang L; Wang C; Qu X; Pretorius RG; Wu R
J Low Genit Tract Dis; 2017 Jan; 21(1):12-16. PubMed ID: 27851695
[TBL] [Abstract][Full Text] [Related]
38. New concepts on risk factors of HPV and novel screening strategies for cervical cancer precursors.
Syrjänen K
Eur J Gynaecol Oncol; 2008; 29(3):205-21. PubMed ID: 18592782
[TBL] [Abstract][Full Text] [Related]
39. [Prevalence of human papillomavirus infection and risk of cervical cancer or precancerous lesions in 15 years follow up: a prospective cohort study].
Zhang Q; Hu SY; Feng RM; Dong L; Chen F; Zhang X; Pan QJ; Ma JF; Shi SD; Zhao FH; Qiao YL
Zhonghua Zhong Liu Za Zhi; 2016 Oct; 38(10):792-797. PubMed ID: 27784468
[No Abstract] [Full Text] [Related]
40. Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs.
Zhao D; Zhang L; Xie F; Peng D; Wei J; Jiang L; Zhang S; Qi D
BMC Cancer; 2020 Aug; 20(1):810. PubMed ID: 32847541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
